Cargando…
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597216/ https://www.ncbi.nlm.nih.gov/pubmed/35989091 http://dx.doi.org/10.3350/cmh.2022.0208 |
_version_ | 1784816043801182208 |
---|---|
author | Pirola, Carlos J. Sookoian, Silvia |
author_facet | Pirola, Carlos J. Sookoian, Silvia |
author_sort | Pirola, Carlos J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9597216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-95972162022-10-31 Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait Pirola, Carlos J. Sookoian, Silvia Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2022-10 2022-08-19 /pmc/articles/PMC9597216/ /pubmed/35989091 http://dx.doi.org/10.3350/cmh.2022.0208 Text en Copyright © 2022 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Pirola, Carlos J. Sookoian, Silvia Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
title | Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
title_full | Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
title_fullStr | Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
title_full_unstemmed | Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
title_short | Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
title_sort | repurposing drugs to target nonalcoholic steatohepatitis: auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597216/ https://www.ncbi.nlm.nih.gov/pubmed/35989091 http://dx.doi.org/10.3350/cmh.2022.0208 |
work_keys_str_mv | AT pirolacarlosj repurposingdrugstotargetnonalcoholicsteatohepatitisauranofinagoldorganicmoleculecomplexforthetreatmentofaspecifccomplextrait AT sookoiansilvia repurposingdrugstotargetnonalcoholicsteatohepatitisauranofinagoldorganicmoleculecomplexforthetreatmentofaspecifccomplextrait |